METTL3 and metabolic dysfunction-associated steatotic liver disease: In summary, our study suggested the regulatory function of Mettl3-mediated epigenetic modification in mouse liver lipid metabolism, expanding our understanding of the regulatory network outside of transcriptomics in mammalian liver lipid metabolism and NAFLD pathogenesis.